综述

巨细胞病毒疫苗研究进展

  • 陈守彬 刘菊
展开
  • 610023 成都生物制品研究所有限责任公司质量运营部

网络出版日期: 2025-08-16

Progress in research of cytomegalovirus vaccines

Expand
  • Quality Operation Department, Chengdu Institute of biological Products Co., Ltd., Chengdu 610023, China

Online published: 2025-08-16

摘要

人巨细胞病毒(HCMV)普遍存在于各类人群中 ,是先天性病毒感染的最常见原因。在过去的十年中HCMV疫苗的研制取得了巨大进展,此文概述了HCMV疫苗的临床试验和临床前研发现状,重点介绍了近5年来HCMV疫苗和生物学研究进展。

本文引用格式

陈守彬 刘菊 . 巨细胞病毒疫苗研究进展[J]. 国际生物制品学杂志, 2012 , 35(1) : 15 -20 . DOI: 10.3760/cma.j.issn.1673-4211.2012.01.004

Abstract

Human cytomegalovirus (HCMV) is ubiquitous in various populations, and is the most common cause of congenital viral infection . During the last decade, enormous progress has been made in development of HCMV vaccines. This article summaries the current state of clinical trials and preclinical development of HCMV vaccines, with an emphasis on studies of HCMV vaccines and biology that have been conducted in the past 5 years.
文章导航

/